Endometriosis & adolescents: Overcoming the diagnostic delay via education

Endometriosis & adolescents: Overcoming the diagnostic delay via education By Eylül GÜN

Although the diagnosis of endometriosis is still not timely even in adults, due to its common under- or misdiagnosis in adolescents, the diagnostic delay may further cause the adolescent women to wait to seek medical treatment.  A group of researchers…

Key Points Lay Summary

Body mass index, the incidence of endometriosis and the severity of dysmenorrhoea

Body mass index, the incidence of endometriosis and the severity of dysmenorrhoea By Timur Seckin

According to a case-control study conducted by researchers from China, there is no association between body mass index (BMI) and the incidence of endometriosis. This finding contrasts with the conventional knowledge that low BMI is a risk factor for endometriosis.…

Key Points Lay Summary

Case-control study to develop a questionnaire for early diagnosis of endometriosis

Case-control study to develop a questionnaire for early diagnosis of endometriosis By Nadire Duru

Endometriosis, which affects 5–10% of women of reproductive age, is a chronic gynecological disease characterized by the presence of endometrial glands and stroma outside the uterus, associated with several discomforts such as pelvic pain, menstrual disorders, and infertility. Ultrasound evaluation…

Key Points Lay Summary

Is there any association between menstrual pain and ovarian cancer?

Is there any association between menstrual pain and ovarian cancer? By Yu Yu

Inflammation may be important in ovarian carcinogenesis. Epidemiological studies show that inflammatory conditions such as endometriosis and pelvic inflammatory disease have been associated with an increased risk of ovarian cancer, while regular use of non-steroidal anti-inflammatory drugs has reduced associated…

Key Points Lay Summary

Elagolix (ABT-620) for endometriosis pain?

Elagolix (ABT-620) for endometriosis pain? By Yu Yu

Elagolix is an orally active gonadotropin-releasing hormone antagonist that has just recently completed Phase 3 clinical trial for endometriosis-associated pain (NCT01931670). The review article by Alessandro et al in Archives of Gynecology and Obstetrics summarized the current research findings on…

Key Points Lay Summary